Man Group PLC Aurinia Pharmaceuticals Inc. Transaction History

Man Group PLC

$35.6 Billion
Q4 2024

A detailed history of Man Group PLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Man Group PLC holds 19,742 shares of AUPH stock, worth $155,369. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,742

Previous 99,371 80.13%

Holding current value

$155,369

Previous $728,000 75.69%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$6.75 - $10.44 $537,495 - $831,326	-79,629 Reduced 80.13%	19,742 $177,000
Q3 2024 Nov 14, 2024	BUY	$5.32 - $7.33 $528,653 - $728,389	99,371 New	99,371 $728,000
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $316,784 - $682,549	-28,983 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $815,720 - $1.18 Million	-81,572 Reduced 73.78%	28,983 $376,000
Q1 2021 May 17, 2021	SELL	$12.3 - $18.73 $2.49 Million - $3.8 Million	-202,628 Reduced 64.7%	110,555 $1.44 Million
Q4 2020 Feb 16, 2021	SELL	$12.94 - $16.05 $104,425 - $129,523	-8,070 Reduced 2.51%	313,183 $4.33 Million
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $78,111 - $98,660	5,922 Added 1.88%	321,253 $4.73 Million
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $3.27 Million - $4.25 Million	231,743 Added 277.24%	315,331 $5.12 Million
Q1 2020 May 15, 2020	BUY	$11.34 - $21.46 $947,887 - $1.79 Million	83,588 New	83,588 $1.21 Million
Q1 2019 May 15, 2019	SELL	$6.06 - $7.64 $126,653 - $159,676	-20,900 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$5.08 - $6.83 $186,944 - $251,344	-36,800 Reduced 63.78%	20,900 $143,000
Q3 2018 Nov 14, 2018	SELL	$5.27 - $6.64 $4,216 - $5,312	-800 Reduced 1.37%	57,700 $383,000
Q2 2018 Aug 14, 2018	BUY	$5.06 - $6.36 $130,041 - $163,452	25,700 Added 78.35%	58,500 $329,000
Q1 2018 May 15, 2018	BUY	$4.85 - $5.99 $159,080 - $196,472	32,800 New	32,800 $170,000

Others Institutions Holding AUPH

# of Institutions

227

Shares Held

58.9M

Call Options Held

949K

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.12B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account